Ameritas Investment Partners, Inc.

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 1055980 LINCOLN, NE

Position in BMRN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,035,429

+$36,135 QoQ

Shares Held

35,572

+0.5% QoQ

Ownership

0.018%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#215

of 561 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Ameritas Investment Partners, Inc. holds $62,741,652 across 267 Biotechnology names. BMRN ranks #9 (3.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	12,422	$6,170,379
2	EXEL	Exelixis, Inc.	75,969	$4,133,473
3	HALO	Halozyme Therapeutics, Inc.	40,729	$3,187,858
4	CYTK	Cytokinetics Inc	36,992	$3,151,348
5	ROIV	Roivant Sciences Ltd.	83,064	$2,939,634
6	REGN	Regeneron Pharmaceuticals, Inc.	4,593	$2,863,919
7	JAZZ	Jazz Pharmaceuticals plc	11,547	$2,782,480
8	ARWR	Arrowhead Pharmaceuticals, Inc.	25,923	$2,112,983

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,035,429	35,572	+0.5%	Shares	Other	2026-08-13
2026-03-31	$1,999,294	35,392	+0.5%	Shares	Other	2026-05-13
2025-12-31	$2,092,411	35,208	-2.2%	Shares	Other	2026-02-11
2025-09-30	$1,949,435	35,994	-3.3%	Shares	Other	2025-11-10
2025-06-30	$2,046,807	37,235	-0.7%	Shares	Other	2025-08-12
2025-03-31	$2,650,733	37,498	-1.8%	Shares	Other	2025-05-12
2024-12-31	$2,509,111	38,173	-2.3%	Shares	Other	2025-02-13
2024-09-30	$2,745,457	39,059	-3.3%	Shares	Other	2024-11-13
2024-06-30	$3,325,061	40,387	+1066.2%	Shares	Other	2024-08-13
2020-09-30	$263,465	3,463	-3.3%	Shares	Other	2020-11-13
2020-06-30	$441,557	3,580	0.0%	Shares	Other	2020-08-05
2020-03-31	$302,510	3,580	—	Shares	Other	2020-05-13
No filing history on record for this holder in this stock.